doctia glp-1 reviews A Review in Nature Endocrinology discusses why patients discontinue receptor agonists and tirzepatide, the metabolic and cardiovascular effects of this discontinuation, and the need for additional research on how to Pros & cons of GLP-1

285 , 723730 (2010) Runge, S., Thgersen, H., Madsen, K., Lau, J

The slower erosion curve for biologics (20-30% biosimilar market share after two years, versus 80-90% for small molecules) means that even after formal loss of exclusivity, the price compression that Cost Plus needs to add a drug to its formulary at a meaningful patient savings may not materialize for three to four years post-LOE

This is a mechanical issue, not a toxicity issueand it is largely preventable with proper lifestyle integration

GLP-1R KO can lead to increased appetite, contributing to weight gain

For safety, any semaglutide that appears unusual or has passed its beyond-use date should be discarded

[2] Son cifras grandes, y por eso los medicamentos GLP-1 son tendencia